Further evidence for the association of GAL , GALR1 and NPY1R variants with Opioid Dependence
Author(s) -
Matthew Randesi,
Orna Levran,
Wim van den Brink,
Peter Blanken,
Jan M. van Ree,
Jürg Ott,
Mary Jeanne Kreek
Publication year - 2020
Publication title -
pharmacogenomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.541
H-Index - 91
eISSN - 1744-8042
pISSN - 1462-2416
DOI - 10.2217/pgs-2020-0045
Subject(s) - heroin , snp , opioid , single nucleotide polymorphism , addiction , genetic association , methadone maintenance , medicine , methadone , association (psychology) , heroin addiction , gene , psychiatry , clinical psychology , pharmacology , genetics , psychology , drug , biology , genotype , receptor , psychotherapist
Aim: Heroin addiction is a chronic, relapsing disease that has genetic and environmental, including drug-induced, contributions. Stress influences the development of addictions. This study was conducted to determine if variants in stress-related genes are associated with opioid dependence (OD). Patients & methods: One hundred and twenty variants in 26 genes were analyzed in 597 Dutch subjects. Patients included 281 OD in methadone maintenance with or without heroin-assisted treatment and 316 controls. Results: Twelve SNPs in seven genes showed a nominally significant association with OD. Experiment-wise significant associations (p < 0.05) were found for three SNP pairs, through an interaction effect: NPY1R / GAL rs4691910/rs1893679, NPY1R / GAL rs4691910/rs3136541 and GALR1/GAL rs9807208/rs3136541. Conclusion: This study lends more evidence to previous reports of association of stress-related variants with heroin dependence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom